D vs RXRX · P/E 21, rev $16.51B vs rev $58.8M
Dominion Energy Inc (D) versus Recursion Pharmaceuticals Inc (RXRX) — a side-by-side from cached financials, not a winner call.
Dominion Energy Inc (D) is a utilities - regulated electric company listed on US.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Latest reported D revenue for 2025-12-31 was $16.51B. Net income was $3.00B. Revenue was up 385.5% from 2024-12-31 to 2025-12-31. D currently screens at market cap $47.07B and trailing P/E 21.3.
Latest reported RXRX revenue for 2024-12-31 was $58.8M. Net income was -$463.7M. Revenue was up 32.0% from 2023-12-31 to 2024-12-31. RXRX currently screens at market cap $1.75B.
D currently screens at market cap $47.07B and trailing P/E 21.3. RXRX currently screens at market cap $1.75B.
Not investment advice. Open the D and RXRX stock pages for the full models.
Not investment advice.